NCT00199420View on ClinicalTrials.gov

A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa

PHASE3CompletedINTERVENTIONAL
Enrollment

580

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

December 31, 2005

Conditions
Parkinson's Disease
Interventions
DRUG

Istradefylline (KW-6002)

Trial Locations (2)

08540

Kyowa Pharmaceutical Inc., Princeton

Kyowa Pharmaceutical, Princeton

Sponsors

Lead Sponsor

Kyowa Kirin, Inc.
All Listed Sponsors
lead

Kyowa Kirin, Inc.

INDUSTRY